C. Courtillot, Z. Chakhtoura, R. Bogorad, C. Genestie, S. Bernichtein et al., Characterization of Two Constitutively Active Prolactin Receptor Variants in a Cohort of 95 Women with Multiple Breast Fibroadenomas, The Journal of Clinical Endocrinology & Metabolism, vol.95, issue.1, 2010.
DOI : 10.1210/jc.2009-1494

R. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan et al., Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors, Proceedings of the National Academy of Sciences, vol.105, issue.38, pp.14533-14541, 2008.
DOI : 10.1073/pnas.0800685105

F. Hassiotou and D. Geddes, Anatomy of the human mammary gland: Current status of knowledge, Clinical Anatomy, vol.101, issue.1, pp.29-48, 2013.
DOI : 10.1002/ca.22165

D. Ramsay, J. Kent, R. Hartmann, and P. Hartmann, Anatomy of the lactating human breast redefined with ultrasound imaging, Journal of Anatomy, vol.2, issue.4, pp.525-559, 2005.
DOI : 10.1542/peds.113.2.361

W. Zhu and C. Nelson, Adipose and mammary epithelial tissue engineering, Biomatter, vol.26, issue.3, 2013.
DOI : 10.1007/s10911-010-9192-y

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749276

D. Waugh and E. Van-der-hoeven, Fine structure of the human adult female breast, Lab Investig J Tech Methods Pathol, vol.11, pp.220-228, 1962.

J. Spratt, W. Donegan, and G. Tobin, Gross Anatomy of the Breast. Cancer of the breast, Saunders WB, p.22, 2002.

A. Chagpar, R. Martin, C. Chao, S. Wong, M. Edwards et al., Validation of Subareolar and Periareolar Injection Techniques for Breast Sentinel Lymph Node Biopsy, Archives of Surgery, vol.139, issue.6, pp.614-622, 1960.
DOI : 10.1001/archsurg.139.6.614

J. Harness, T. Vetter, and A. Salibian, Areola and Nipple-Areola-Sparing Mastectomy for Breast Cancer Treatment and Risk Reduction: Report of an Initial Experience in a Community Hospital Setting, Annals of Surgical Oncology, vol.15, issue.4, pp.917-939, 2011.
DOI : 10.1245/s10434-010-1365-9

A. Birkenfeld and N. Kase, Functional anatomy and physiology of the female breast, Obstet Gynecol Clin North Am, vol.21, issue.3, pp.433-477, 1994.

H. Tobon and H. Salazar, Ultrastructure of the Human Mammary Gland. I. Development of the Fetal Gland Throughout Gestation, The Journal of Clinical Endocrinology & Metabolism, vol.39, issue.3, pp.443-56, 1974.
DOI : 10.1210/jcem-39-3-443

J. Kuhns and D. Ackerman, Microscopic Anatomy of the Breast. Cancer of the breast, pp.21-28, 2002.

J. Russo and I. Russo, Development of the human breast, Maturitas, vol.49, issue.1, pp.2-15, 2004.
DOI : 10.1016/j.maturitas.2004.04.011

A. Parks, The micro-anatomy of the breast, Ann R Coll Surg Engl, vol.25, pp.235-51, 1959.

P. Vogel, N. Georgiade, B. Fetter, F. Vogel, K. Mccarty et al., The correlation of histologic changes in the human breast with the menstrual cycle, Am J Pathol, 1981.

H. Tobon and H. Salazar, Ultrastructure of the Human Mammary Gland. II. Postpartum Lactogenesis, The Journal of Clinical Endocrinology & Metabolism, vol.40, issue.5, pp.834-878, 1975.
DOI : 10.1210/jcem-40-5-834

S. Battersby and T. Anderson, Histological changes in breast tissue that characterize recent pregnancy, Histopathology, vol.130, issue.4, pp.415-424, 1989.
DOI : 10.1111/j.1365-2559.1989.tb01593.x

S. Hutson, P. Cowen, and C. Bird, Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer., Journal of Clinical Pathology, vol.38, issue.3, 1985.
DOI : 10.1136/jcp.38.3.281

F. Kuttenn, S. Fournier, J. Durand, and P. Mauvais-jarvis, Estradiol and Progesterone Receptors in Human Breast Fibroadenomas, The Journal of Clinical Endocrinology & Metabolism, vol.52, issue.6, pp.1225-1234, 1981.
DOI : 10.1210/jcem-52-6-1225

L. Hennighausen and G. Robinson, Information networks in the mammary gland, Nature Reviews Molecular Cell Biology, vol.9, issue.9, pp.715-740, 2005.
DOI : 10.1038/nrm1714

M. Sternlicht, Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis, Breast Cancer Research, vol.3, issue.1, p.201, 2006.
DOI : 10.1038/ncb0901-823

J. Couse, J. Lindzey, K. Grandien, J. Gustafsson, and K. Korach, Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse, Endocrinology, vol.138, issue.11, pp.4613-4634, 1997.

G. Cunha, J. Wiesen, Z. Werb, P. Young, Y. Hom et al., Paracrine Mechanisms of Mouse Mammary Ductal Growth, Adv Exp Med Biol, vol.480, pp.93-100, 2000.
DOI : 10.1007/0-306-46832-8_11

A. Gompel, C. Malet, P. Spritzer, J. Lalardrie, F. Kuttenn et al., Progestin Effect on Cell Proliferation and 17??-Hydroxysteroid Dehydrogenase Activity in Normal Human Breast Cells in Culture*, The Journal of Clinical Endocrinology & Metabolism, vol.63, issue.5, pp.1174-80, 1986.
DOI : 10.1210/jcem-63-5-1174

M. Eisen, The Occurence of Benign and Malignant Mammary Lesions in Rats Treated with Crystalline Estrogen, Cancer Res, pp.632-676, 1942.

J. Barrat, B. De-lignières, L. Marpeau, L. Larue, S. Fournier et al., The in vivo effect of the local administration of progesterone on the mitotic activity of human ductal breast tissue. Results of a pilot study], J Gynécologie Obstétrique Biol Reprod, vol.19, issue.3, pp.269-74, 1990.

K. Chang, T. Lee, G. Linares-cruz, S. Fournier, and B. De-ligniéres, Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo**Supported by Besins-Iscovesco, Paris, France and Orient Europharma, Taipei, Taiwan.??????Presented in part at the 7th International Congress on the Menopause, Stockholm, Sweden, June 20 to 24, 1993., Fertility and Sterility, vol.63, issue.4, pp.785-91, 1995.
DOI : 10.1016/S0015-0282(16)57482-2

C. Brisken, S. Park, T. Vass, J. Lydon, O. Malley et al., A paracrine role for the epithelial progesterone receptor in mammary gland development, Proceedings of the National Academy of Sciences, vol.95, issue.9, pp.5076-81, 1998.
DOI : 10.1073/pnas.95.9.5076

L. Hennighausen and G. Robinson, Signaling Pathways in Mammary Gland Development, Developmental Cell, vol.1, issue.4, pp.467-75, 2001.
DOI : 10.1016/S1534-5807(01)00064-8

H. Lee and C. Ormandy, Interplay between progesterone and prolactin in mammary development and implications for breast cancer, Molecular and Cellular Endocrinology, vol.357, issue.1-2, pp.101-108, 2012.
DOI : 10.1016/j.mce.2011.09.020

A. Obr and D. Edwards, The biology of progesterone receptor in the normal mammary gland and in breast cancer, Molecular and Cellular Endocrinology, vol.357, issue.1-2, pp.4-17, 2012.
DOI : 10.1016/j.mce.2011.10.030

J. Prud-'homme, C. Malet, A. Gompel, J. Lalardrie, C. Ochoa et al., 17 beta- Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures, Endocrinology, vol.114, issue.5, pp.1483-1492, 1984.

P. Touraine and V. Goffin, Physiologie de la prolactine. EMC -Endocrinol, pp.50-76, 2005.

C. Bole-feysot, V. Goffin, M. Edery, N. Binart, and P. Kelly, Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice, Endocrine Reviews, vol.19, issue.3, pp.225-68, 1998.
DOI : 10.1210/edrv.19.3.0334

P. Touraine, J. Martini, B. Zafrani, J. Durand, F. Labaille et al., Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues, J Clin Endocrinol Metab, 1998.

N. Binart, P. Imbert-bollore, N. Baran, C. Viglietta, and P. Kelly, A Short Form of the Prolactin (PRL) Receptor Is Able to Rescue Mammopoiesis in Heterozygous PRL Receptor Mice, Molecular Endocrinology, vol.17, issue.6, pp.1066-74, 2003.
DOI : 10.1210/me.2002-0181

C. Clevenger, P. Furth, S. Hankinson, and L. Schuler, The Role of Prolactin in Mammary Carcinoma, Endocrine Reviews, vol.24, issue.1, pp.1-27, 2003.
DOI : 10.1210/er.2001-0036

H. Wennbo, M. Gebre-medhin, A. Gritli-linde, C. Ohlsson, O. Isaksson et al., Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice., Journal of Clinical Investigation, vol.100, issue.11, pp.2744-51, 1997.
DOI : 10.1172/JCI119820

S. Tworoger, A. Eliassen, X. Zhang, J. Qian, P. Sluss et al., A 20-Year Prospective Study of Plasma Prolactin as a Risk Marker of Breast Cancer Development, Cancer Research, vol.73, issue.15, pp.4810-4819, 2013.
DOI : 10.1158/0008-5472.CAN-13-0665

K. Tikk, D. Sookthai, T. Johnson, S. Rinaldi, I. Romieu et al., Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort, Annals of Oncology, vol.25, issue.7, 2014.
DOI : 10.1093/annonc/mdu150

I. Fernandez, P. Touraine, and V. Goffin, Prolactin and human tumourogenesis, J Neuroendocrinol, vol.22, issue.7, pp.771-778, 2010.

L. Hughes, Unifying Concept for Benign Disorders of the Breast: ANDI. Cancer of the breast, pp.57-66, 2002.

W. Dupont and D. Page, Risk Factors for Breast Cancer in Women with Proliferative Breast Disease, New England Journal of Medicine, vol.312, issue.3, pp.146-51, 1985.
DOI : 10.1056/NEJM198501173120303

L. Hughes, R. Mansel, and D. Webster, ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI): A NEW PERSPECTIVE ON PATHOGENESIS AND NOMENCLATURE OF BENIGN BREAST DISORDERS, The Lancet, vol.330, issue.8571, pp.1316-1325, 1987.
DOI : 10.1016/S0140-6736(87)91204-9

C. Courtillot, G. Plu-bureau, N. Binart, C. Balleyguier, B. Sigal-zafrani et al., Benign Breast Diseases, Journal of Mammary Gland Biology and Neoplasia, vol.31, issue.9, pp.325-360, 2005.
DOI : 10.1007/s10911-006-9006-4

H. El-wakeel and H. Umpleby, Systematic review of fibroadenoma as a risk factor for breast cancer, The Breast, vol.12, issue.5, pp.302-309, 2003.
DOI : 10.1016/S0960-9776(03)00123-1

M. Nielsen, J. Thomsen, S. Primdahl, U. Dyreborg, and J. Andersen, Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies, British Journal of Cancer, vol.56, issue.6, pp.814-823, 1987.
DOI : 10.1038/bjc.1987.296

C. Goehring and A. Morabia, Epidemiology of Benign Breast Disease, with Special Attention to Histologic Types, Epidemiologic Reviews, vol.19, issue.2, pp.310-337, 1997.
DOI : 10.1093/oxfordjournals.epirev.a017960

R. Greenberg, Y. Skornick, and O. Kaplan, Management of breast fibroadenomas, Journal of General Internal Medicine, vol.83, issue.suppl, pp.640-645, 1998.
DOI : 10.1046/j.1525-1497.1998.cr188.x

H. Aslam, S. Saleem, H. Shaikh, N. Shahid, A. Mughal et al., Clinico- pathological profile of patients with breast diseases, Diagnostic Pathology, vol.56, issue.2, p.77, 2013.
DOI : 10.1186/1746-1596-8-77

R. Santen and R. Mansel, Benign Breast Disorders, New England Journal of Medicine, vol.353, issue.3, pp.275-85, 2005.
DOI : 10.1056/NEJMra035692

D. Dent, P. Cant, and . Fibroadenoma, Fibroadenoma, World Journal of Surgery, vol.61, issue.Suppl. 56, pp.706-716, 1989.
DOI : 10.1007/BF01658418

J. Dixon, V. Dobie, J. Lamb, J. Walsh, and U. Chetty, Assessment of the acceptability of conservative management of fibroadenoma of the breast, British Journal of Surgery, vol.74, issue.2, pp.264-269, 1996.
DOI : 10.1002/bjs.1800830238

N. Carty, C. Carter, C. Rubin, D. Ravichandran, G. Royle et al., Management of fibroadenoma of the breast, Ann R Coll Surg Engl, vol.77, issue.2, pp.127-157, 1995.

S. Wilkinson, T. Anderson, E. Rifkind, U. Chetty, and A. Forrest, Fibroadenoma of the breast: A follow-up of conservative management, British Journal of Surgery, vol.25, issue.4, pp.390-391, 1989.
DOI : 10.1002/bjs.1800760424

P. Cant, M. Madden, M. Coleman, and D. Dent, Non-operative management of breast masses diagnosed as fibroadenoma, British Journal of Surgery, vol.40, issue.6, pp.792-796, 1995.
DOI : 10.1002/bjs.1800820624

L. Hughes, Classification of benign breast disorders: The ANDI classification based on physiological processes within the normal breast, British Medical Bulletin, vol.47, issue.2, pp.251-258, 1991.
DOI : 10.1093/oxfordjournals.bmb.a072467

C. Organ and B. Organ, Fibroadenoma of the female breast: a critical clinical assessment, J Natl Med Assoc, vol.75, issue.7, pp.701-705, 1983.

R. Zhang, S. Bevan, P. Sun, J. Lu, and Y. Peng, Unusual presentation of multiple fibroadenomas in bilateral breasts and axillary accessory breast, Breast Cancer Basic Clin Res, vol.6, pp.95-104, 2012.

M. Guray and A. Sahin, Benign Breast Diseases: Classification, Diagnosis, and Management, The Oncologist, vol.11, issue.5, pp.435-484, 2006.
DOI : 10.1634/theoncologist.11-5-435

M. Sosin and E. Feldman, Giant juvenile fibroadenoma: A case and review of novel modalities in treatment, Breast Disease, vol.34, issue.1, pp.35-43, 2012.
DOI : 10.3233/BD-130342

A. Vijaykumar, M. Ajitha, B. Shivaswamy, and N. Srinivasan, A Systematic Study on Fibroadenoma of the Breast, Eur J Surg Sci, vol.3, issue.3, pp.80-85, 2012.

J. Dixon, Cystic disease and fibroadenoma of the breast: Natural history and relation to breast cancer risk, British Medical Bulletin, vol.47, issue.2, pp.258-71, 1991.
DOI : 10.1093/oxfordjournals.bmb.a072468

F. Archer and M. Omar, The fine structure of fibro-adenoma of the human breast, The Journal of Pathology, vol.30, issue.2, pp.113-120, 1969.
DOI : 10.1002/path.1710990204

R. Kaya, H. Pestereli, G. Erdogan, K. Gülkesen, and S. Karaveli, Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: Is it helpful?, Pathology & Oncology Research, vol.19, issue.3, pp.213-219, 2001.
DOI : 10.1007/BF03032352

N. Borecky and M. Rickard, Preoperative diagnosis of carcinoma within fibroadenoma on screening mammograms, Journal of Medical Imaging and Radiation Oncology, vol.9, issue.1, pp.64-71, 2008.
DOI : 10.1016/j.breast.2006.05.004

A. Hababou, O. Ouhioun, and P. Detraux, Imagerie du sein bénin. EMC -Gynécologie, 2012.

S. Datta and E. Davies, Benign breast disease. Surg Oxf, pp.22-28, 2013.

S. Panda, B. Patro, J. Mishra, R. Dora, and B. Subudhi, Multiple fibroadenomas in bilateral breasts of a 46-year-old Indian woman ??? A case report, International Journal of Surgery Case Reports, vol.5, issue.5, pp.262-266, 2014.
DOI : 10.1016/j.ijscr.2013.12.013

P. Guyer, The use of ultrasound in benign breast disorders, World Journal of Surgery, vol.81, issue.6, 1989.
DOI : 10.1007/BF01658416

J. Harvey, M. Mahoney, M. Newell, L. Bailey, L. Barke et al., ACR Appropriateness Criteria Palpable Breast Masses, J Am Coll Radiol JACR, 2013.

M. Sawa, N. Kawai, M. Sato, T. Takeuchi, T. Tamaki et al., Fibroadenoma of the axillary accessory breast: diagnostic value of dynamic magnetic resonance imaging, Japanese Journal of Radiology, vol.53, issue.8, pp.613-620, 2010.
DOI : 10.1007/s11604-010-0466-5

J. Pasqualini, J. Cortes-prieto, G. Chetrite, M. Talbi, and A. Ruiz, Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma, International Journal of Cancer, vol.6, issue.6, pp.639-682, 1997.
DOI : 10.1002/(SICI)1097-0215(19970317)70:6<639::AID-IJC2>3.0.CO;2-W

A. Sapino, M. Bosco, P. Cassoni, I. Castellano, R. Arisio et al., Estrogen receptorbeta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast, Mod Pathol Off J U S Can Acad Pathol Inc, vol.19, issue.4, pp.599-606, 2006.

M. Baxi, A. Agarwal, A. Mishra, G. Agarwal, and S. Mishra, Multiple bilateral giant juvenile fibroadenomas of breast, Eur J Surg Acta Chir, vol.166, issue.10, pp.828-858, 2000.

G. Plu-bureau, P. Touraine, and P. Mauvais-jarvis, Interactions Between Estradiol and Progesterone in Normal Breast, Endocrinology of Breast Cancer, pp.21-37, 1999.
DOI : 10.1007/978-1-59259-699-7_2

G. Branchini, L. Schneider, R. Cericatto, E. Capp, and I. Brum, Progesterone receptors A and B and estrogen receptor alpha expression in normal breast tissue and fibroadenomas, Endocrine, vol.93, issue.2, pp.459-66, 2009.
DOI : 10.1007/s12020-009-9176-0

J. Harvey, B. Nicholson, A. Lorusso, M. Cohen, and V. Bovbjerg, Short-Term Follow-Up of Palpable Breast Lesions With Benign Imaging Features: Evaluation of 375 Lesions in 320 Women, American Journal of Roentgenology, vol.193, issue.6, pp.1723-1753, 2009.
DOI : 10.2214/AJR.09.2811

J. Hubbard, K. Cagle, J. Davis, K. Kaups, and M. Kodama, Criteria for excision of suspected fibroadenomas of??the??breast, The American Journal of Surgery, vol.209, issue.2, 2014.
DOI : 10.1016/j.amjsurg.2013.12.037

P. Cant, M. Madden, P. Close, G. Learmonth, E. Hacking et al., Case for conservative management of selected fibro-adenomas of the breast, British Journal of Surgery, vol.2, issue.9, 1987.
DOI : 10.1002/bjs.1800740936

A. Kuijper, E. Mommers, E. Van-der-wall, and P. Van-diest, Histopathology of Fibroadenoma of the Breast, American Journal of Clinical Pathology, vol.115, issue.5, pp.736-778, 2001.
DOI : 10.1309/F523-FMJV-W886-3J38

A. Van-osdol, J. Landercasper, J. Andersen, R. Ellis, E. Gensch et al., Determining Whether Excision of All Fibroepithelial Lesions of the Breast Is Needed to Exclude Phyllodes Tumor, JAMA Surgery, vol.149, issue.10, 2014.
DOI : 10.1001/jamasurg.2014.73

J. Bernardes, M. Seixas, G. Lima, L. Marinho, and L. Gebrim, The Effect of Tamoxifen on PCNA Expression in Fibroadenomas, The Breast Journal, vol.13, issue.4, pp.302-308, 2003.
DOI : 10.1093/jnci/90.18.1371

Y. Wu, S. Chen, C. Chen, Y. Kuo, L. Tseng et al., Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy, World Journal of Surgical Oncology, vol.12, issue.1, p.335, 2014.
DOI : 10.1007/BF00311918

W. Dupont, D. Page, F. Parl, C. Vnencak-jones, W. Plummer et al., Long-Term Risk of Breast Cancer in Women with Fibroadenoma, New England Journal of Medicine, vol.331, issue.1, pp.10-15, 1994.
DOI : 10.1056/NEJM199407073310103

L. Hartmann, T. Sellers, M. Frost, W. Lingle, A. Degnim et al., Benign Breast Disease and the Risk of Breast Cancer, New England Journal of Medicine, vol.353, issue.3, pp.229-266, 2005.
DOI : 10.1056/NEJMoa044383

R. Mcdivitt, J. Stevens, N. Lee, P. Wingo, G. Rubin et al., Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer, pp.1408-1422, 1992.

V. Naraynsingh and G. Raju, Familial bilateral multiple fibroadenomas of the breast., Postgraduate Medical Journal, vol.61, issue.715, pp.439-479, 1985.
DOI : 10.1136/pgmj.61.715.439

H. Yu, T. Rohan, M. Cook, G. Howe, and A. Miller, Risk Factors for Fibroadenoma: A Case-Control Study in Australia, American Journal of Epidemiology, vol.135, issue.3, pp.247-58, 1992.
DOI : 10.1093/oxfordjournals.aje.a116278

S. Bidgoli and T. Eftekhari, Role of exogenous and endogenous sources of estrogen on the incidence of breast fibroadenoma: case-control study in Iran, Asian Pac J Cancer Prev APJCP, vol.12, issue.5, pp.1289-93, 2011.

T. Rohan, M. Cook, and J. Baron, Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study., Journal of Epidemiology & Community Health, vol.43, issue.4, pp.362-370, 1989.
DOI : 10.1136/jech.43.4.362

F. Xue, W. Willett, B. Rosner, S. Hankinson, and K. Michels, Cigarette Smoking and the Incidence of Breast Cancer, Archives of Internal Medicine, vol.171, issue.2, pp.125-158, 2011.
DOI : 10.1001/archinternmed.2010.503

L. Brinton, M. Vessey, R. Flavel, and D. Yeates, RISK FACTORS FOR BENIGN BREAST DISEASE, American Journal of Epidemiology, vol.113, issue.3, pp.203-217, 1981.
DOI : 10.1093/oxfordjournals.aje.a113089

H. Ma, K. Henderson, J. Sullivan-halley, L. Duan, S. Marshall et al., Pregnancy-related factors and the risk of breast carcinoma in situand invasive breast cancer among postmenopausal women in the California Teachers Study cohort, Breast Cancer Research, vol.93, issue.3, p.35, 2010.
DOI : 10.1038/sj.bjc.6602712

S. Bernardi, A. Londero, S. Bertozzi, L. Driul, D. Marchesoni et al., Breast-feeding and benign breast disease, Journal of Obstetrics and Gynaecology, vol.103, issue.1, pp.58-61
DOI : 10.3109/01443615.2011.613496

T. Heilmann, I. Leuschner, F. Hilpert, C. Kümper, A. Strauss et al., Diagnosis and management of an unilateral giant fibroadenoma of the breast in pregnancy, Archives of Gynecology and Obstetrics, vol.23, issue.12, pp.235-242
DOI : 10.1007/s00404-011-1923-9

J. Yu, M. Kim, H. Cho, H. Liu, S. Han et al., Breast diseases during pregnancy and lactation, Obstetrics & Gynecology Science, vol.56, issue.3, pp.143-59, 2013.
DOI : 10.5468/ogs.2013.56.3.143

M. Vessey and D. Yeates, Oral contraceptives and benign breast disease: an update of findings in a large cohort study, Contraception, vol.76, issue.6, pp.418-442, 2007.
DOI : 10.1016/j.contraception.2007.08.011

G. Plu-bureau, M. Lê, R. Sitruk-ware, J. Thalabard, and P. Mauvais-jarvis, Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease, British Journal of Cancer, vol.70, issue.2, pp.270-277, 1994.
DOI : 10.1038/bjc.1994.291

R. Sitruk-ware and G. Plu-bureau, Exogenous progestagens and the human breast, Maturitas, vol.49, issue.1, pp.58-66, 2004.
DOI : 10.1016/j.maturitas.2004.06.007

H. Ory, P. Cole, B. Macmahon, and R. Hoover, Oral Contraceptives and Reduced Risk of Benign Breast Diseases, New England Journal of Medicine, vol.294, issue.8, pp.419-441, 1976.
DOI : 10.1056/NEJM197602192940804

I. Charreau, G. Plu-bureau, A. Bachelot, G. Contesso, J. Guinebretiére et al., Oral contraceptive use and risk of benign breast disease in a French case-control study of young women, European Journal of Cancer Prevention, vol.2, issue.2, pp.147-54, 1993.
DOI : 10.1097/00008469-199303000-00007

P. Canny, G. Berkowitz, J. Kelsey, and V. Livolsi, FIBROADENOMA AND THE USE OF EXOGENOUS HORMONES, American Journal of Epidemiology, vol.127, issue.3, pp.454-61, 1988.
DOI : 10.1093/oxfordjournals.aje.a114822

T. Rohan and A. Miller, A cohort study of oral contraceptive use and risk of benign breast disease, International Journal of Cancer, vol.2, issue.2, pp.191-197, 1999.
DOI : 10.1002/(SICI)1097-0215(19990719)82:2<191::AID-IJC7>3.0.CO;2-F

P. Mauvais-jarvis, F. Kuttenn, and A. Gompel, Estradiol/Progesterone Interaction in Normal and Pathologic Breast Cells, Annals of the New York Academy of Sciences, vol.114, issue.1 Endocrinology, pp.152-67, 1986.
DOI : 10.1016/0039-128X(79)90139-9

E. Tan-chiu, J. Wang, J. Costantino, S. Paik, C. Butch et al., Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer, JNCI Journal of the National Cancer Institute, vol.95, issue.4, pp.302-309, 2003.
DOI : 10.1093/jnci/95.4.302

M. Rosal and B. Da-silva, Evaluation of estrogen and progesterone receptors in nonneoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study, Breast Cancer Res Treat, 2011.

D. Carlo, R. Muccioli, G. Bellussi, G. Lando, D. Mussa et al., Presence and characterization of prolactin receptors in human benign breast tumours, European Journal of Cancer and Clinical Oncology, vol.20, issue.5, 1984.
DOI : 10.1016/0277-5379(84)90009-9

J. Bonneterre, L. Mauriac, B. Weber, H. Roche, P. Fargeot et al., Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicentre clinical trial, European Journal of Cancer and Clinical Oncology, vol.24, issue.12, 1988.
DOI : 10.1016/0277-5379(88)90097-1

L. Frontini, P. Lissoni, M. Vaghi, M. Perego, S. Pescia et al., of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer, Anticancer Res, vol.24, issue.6, pp.4223-4229, 2004.